-
![5-[4- ((3-Chloro-4- ((3-fluorobenzyl) oxy) phenyl) amino) quinazolin-6-yl] -2-furaldehyde CAS NO.231278-84-5](//cdn.globalso.com/shlzpharma/117.png)
5-[4- ((3-Chloro-4- ((3-fluorobenzyl) oxy) phenyl) amino) quinazolin-6-yl] -2-furaldehyde CAS NO.231278-84-5
Aha ngwaahịa:5-[4- ((3-Chloro-4- ((3-fluorobenzyl) oxy) phenyl) amino) quinazolin-6-yl] -2-furaldehyde
CAS NO:231278-84-5
Ụdị okwu:
Lapatinib etiti
Ụdị emetụtara:Lapatinib di-p-toluenesulfonate, API etiti;ndị etiti;lapatinib n'etiti anọ;lapatinib etiti;lapatinib;intermediates ọgwụ
-
![N-[3-Chloro-4- (3-fluorobenzyloxy) phenyl] -6-iodoquinazolin-4-amine CAS NO.231278-20-9](//cdn.globalso.com/shlzpharma/116.png)
N-[3-Chloro-4- (3-fluorobenzyloxy) phenyl] -6-iodoquinazolin-4-amine CAS NO.231278-20-9
Aha ngwaahịa:N-[3-Chloro-4- (3-fluorobenzyloxy) phenyl]-6-iodoquinazolin-4-amine
CAS NO:231278-20-9
Ụdị okwu:6-Iodo-4-[3-chloro-4- (3-fluorobenzyloxy) anilino] quinazoline;
4-[3-Chloro-4- (3-fluorobenzyloxy) phenylamino] -6-iodoquinazolin;
lapatinib etiti
Ụdị emetụtara:Ndị etiti;mgbochi ọrịa cancer;lapatinib ditosylate etiti;
ọgwụ anticancer lapatinib etiti;etiti ọgwụ;kemịkalụ etiti;
-
2′,3′-Di-O-acetyl-5′-deoxy-5-fuluro-D-cytidine CAS NO.161599-46-8
Aha ngwaahịa:2′,3′-Di-O-acetyl-5′-deoxy-5-fuluro-D-cytidine
CAS NO:161599-46-8
Ụdị okwu:
Capecitabine etiti;
ACETYLFURANOSIDE;
bD-Ribofuranose,5-deoxy-,1,2,3-triacetate
Ụdị emetụtara:5-deoxyribose na mmepụta ya;capecitabine intermediates;ndị etiti;akụrụngwa ọgwụ na etiti;ngwakọta nitrogen;ngwaọrụ;akụrụngwa ọgwụ;organic akụrụngwa;ndị ọzọ biochemical reagent
-
![4-[2- (2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoic acid methyl ester CAS NO.155405-80-4](//cdn.globalso.com/shlzpharma/214.png)
4-[2- (2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoic acid methyl ester CAS NO.155405-80-4
Aha ngwaahịa:4-[2- (2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoic acid methyl ester
CAS NO:155405-80-4
Ụdị okwu:
Pemedolacintermediate;
2-Amino-4,7-dihydro-5-[2-[4- (methoxycarbonyl) phenyl] ethyl] -4-oxo-3H-pyrrolo [2,3-d] pyrimidine;
PMD;
Ụdị emetụtara:Pemetrexed disodium intermediates;ndị etiti;intermediates ọgwụ;chemical akụrụngwa
-
Abiraterone CAS NO.154229-19-3
Aha ngwaahịa:Abirateron
CAS NO:154229-19-3
Ụdị okwu:
Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3beta)-;
CB 7598;
17- (3-Pyridyl) androsta-5,16-dien-3beta-ol;
Ụdị emetụtara:API,Antitumor;Antitumor;Ndị na-emegide Androgen;Ihe mgbakwunye 1;Corticosteroids
-
N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidineamine CAS NO.152460-10-1
Aha ngwaahịa:N- (5-Amino-2-methylphenyl) -4- (3-pyridyl) -2-pyrimidineamine.
CAS NO:152460-10-1
Ụdị okwu:
Imatinib etiti;
Imatinib adịghị ọcha C;
Ụdị emetụtara:Imatinib etiti;imatinib adịghị ọcha;mgbochi tumor;pyrimidine;intermediates ọgwụ;
-
![4-[2- (2-Amino-4,7-dihydro-4-oxo-1H-pymol [2,3-d] pyrimodin-5-yl) ethyl] benzoic acid CAS NO.137281-39-1](//cdn.globalso.com/shlzpharma/211.png)
4-[2- (2-Amino-4,7-dihydro-4-oxo-1H-pymol [2,3-d] pyrimodin-5-yl) ethyl] benzoic acid CAS NO.137281-39-1
Aha ngwaahịa:4-[2- (2-Amino-4,7-dihydro-4-oxo-1H-pymol[2,3-d] pyrimodin-5-yl) ethyl] benzoic acid.
CAS NO:137281-39-1
Ụdị okwu:
Pemetrexed Intermediate;
Ụdị emetụtara:Ndị na-ahụ maka ọgwụ;ndị etiti;ngwaọrụ;pemetrexed usoro;ihe ntụnyere adịghị ọcha;kemikal intermediates;
-
Irinotecan hydrochloride trihydrate CAS NO.136572-09-3
Aha ngwaahịa:Irinotecan hydrochloride trihydrate
CAS NO:136572-09-3
Ụdị okwu:
(1,4'-bipiperidine) -1'-carboxylicacid,4,11-diethyl-3,4,12,14-tetrahydro-4-hydro;
Ụdị emetụtara:API;intermediates ọgwụ;ngwaahịa eke;DNA mebiri emebi;ihe mmepụta nke camptothecin;antitumor;ndị etiti;akụrụngwa ọgwụ;API ọgwụ;obere ihe mgbochi molecule, ngwaahịa eke; Usoro mgbochi tumor
-
2′,2′-Difluoro-2′-deoxycytidine-3′,5′-dibenzoate CAS NO.134790-39-9
Aha ngwaahịa:2′,2′-Difluoro-2′-deoxycytidine-3′,5′-dibenzoate
CAS NO:134790-39-9
Ụdị okwu:
GeMcitabineInterMediate9;
Cytidine, 2′-deoxy-2′,2′-difluoro-,3′,5′-dibenzoate
Ụdị emetụtara:Ndị na-ahụ maka ọgwụ;akụrụngwa; kemịkalụ akụrụngwa;akụrụngwa ọgwụ; ihe ntụnyere adịghị ọcha;kemikal intermediates
-
(3R,4S)-3-Hydroxy-4-phenyl-2-azetidinone CAS NO.132127-34-5
Aha ngwaahịa:(3R, 4S) -3-Hydroxy-4-phenyl-2-azetidinone
CAS NO:132127-34-5
Ụdị okwu:
Docetaxel etiti;
CIS-3-HYDROXY-4-PHENYL-2-AZETIDINONE;
Ụdị emetụtara:etiti ọgwụ; Docetaxel etiti
-
TBTU CAS NO.125700-67-6
Aha ngwaahịa:TBTU
CAS NO:125700-67-6
Ụdị okwu:
2- (1H-Benzotriazole-1-yl) -1,1,3,3-tetramethyluronium tetrafluoroborate;
benzotriazol-1-yl-tetramethyluroniumtetrafluoroborate;
1-[Bis (dimethylamino) methylene] -1H-benzotriazolium3-OxideTetrafluoroborate;
Bortezomib etiti
Ụdị emetụtara:Bortezomib etiti
-
2-Deoxy-2,2-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate CAS NO.122111-11-9
Aha ngwaahịa:2-Deoxy-2,2-difluoro-D-erythro-pentofuranose-3,5-dibenzoate-1-methanesulfonate.
CAS NO:122111-11-9
Ụdị okwu:
GeMcitabine Intermediate 8;
D-ERYTHRO-PENTOFURANOSE,2-DEOXY-2,2-DIFLUORO-,3,5-DIBENZOATE1-METHANESULFONATE;
((2R,3R) -3- (Benzoyloxy) -4,4-difluoro-5- ((Methylsulfonyl) oxy) tetrahydrofuran-2-yl) Methylbenzoate;
3,5-Di-O-benzoyl-2-deoxy-2,2-difluoro-1-O-methanesulfonyl-D-ribofuranoside.
Ụdị emetụtara:intermediate ọgwụ,Gemcitabine hydrochloride etiti
![5-[4- ((3-Chloro-4- ((3-fluorobenzyl) oxy) phenyl) amino) quinazolin-6-yl] -2-furaldehyde CAS NO.231278-84-5](http://cdn.globalso.com/shlzpharma/117.png)
![N-[3-Chloro-4- (3-fluorobenzyloxy) phenyl] -6-iodoquinazolin-4-amine CAS NO.231278-20-9](http://cdn.globalso.com/shlzpharma/116.png)
![4-[2- (2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d] pyrimidin-5-yl) ethyl] benzoic acid methyl ester CAS NO.155405-80-4](http://cdn.globalso.com/shlzpharma/214.png)
![4-[2- (2-Amino-4,7-dihydro-4-oxo-1H-pymol [2,3-d] pyrimodin-5-yl) ethyl] benzoic acid CAS NO.137281-39-1](http://cdn.globalso.com/shlzpharma/211.png)
